Intravenous pentoxifylline does not enhance the pulmonary haemodynamic efficacy of frusemide in strenuously exercising thoroughbred horses.

Authors: Manohar M, Goetz T E, Rothenbaum P, Humphrey S

Journal: Equine veterinary journal

DOI: 10.2746/042516401776249453 PubMed: 11469767Log in to save

Summary

# Editorial Summary Researchers investigated whether combining pentoxifylline with frusemide could provide superior protection against exercise-induced pulmonary haemorrhage (EIPH) by examining pulmonary pressures during maximal exercise in six Thoroughbreds across three randomised treatment protocols: untreated control, frusemide alone (250 mg IV, 4 hours pre-exercise), and frusemide plus pentoxifylline (8.5 mg/kg IV, 15 minutes pre-exercise). Whilst frusemide significantly reduced mean pulmonary arterial, capillary and wedge pressures both at rest and during strenuous exercise (14 m/s on 3.5% gradient), this haemodynamic improvement failed to prevent EIPH; the addition of pentoxifylline produced no further reduction in pulmonary pressures and did not diminish EIPH occurrence, despite causing transient adverse effects (nervousness, fasciculations, sweating, tachycardia) in standing horses. For practitioners managing EIPH, these findings suggest that pentoxifylline offers no additive benefit to frusemide therapy when the primary concern is controlling the intravascular forces driving pulmonary capillary rupture during exercise. The authors acknowledge a limitation: they did not assess whether pentoxifylline altered erythrocyte deformability, which theoretically could influence outcomes through mechanisms independent of haemodynamic modification.

Read the full abstract on PubMed

Practical Takeaways

•Pentoxifylline offers no additional benefit over frusemide alone for reducing exercise-induced pulmonary hypertension or preventing EIPH in Thoroughbred racehorses
•Frusemide effectively reduces pulmonary vascular pressures but does not prevent EIPH in strenuously exercising horses, suggesting EIPH pathophysiology involves factors beyond intravascular pressure alone
•Do not use pentoxifylline as an adjunct therapy with frusemide for EIPH management, as it provides no haemodynamic advantage and causes temporary adverse effects when administered

Key Findings

•Frusemide alone significantly reduced mean pulmonary arterial, capillary and wedge pressures at rest and during maximal exercise, but all 6 horses still experienced EIPH
•Pentoxifylline administration caused acute adverse effects (nervousness, muscular fasciculations, sweating, tachycardia) that resolved within 15 minutes
•Pentoxifylline added to frusemide produced no significant additional reduction in right atrial or pulmonary vascular pressures compared to frusemide alone
•All 6 horses in the frusemide + pentoxifylline group experienced EIPH, with pulmonary haemodynamic pressures not significantly different from frusemide-only treatment

Conditions Studied

exercise-induced pulmonary haemorrhage (eiph)pulmonary hypertension during exercise

Related References

Ureteral ligation prevents the haemodynamic effect of frusemide in pentobarbitol anaesthetised horses.

Hubbell J A E, Hinchcliff K W, Grosenbaugh D A, Beard W L, Beard L A(2002)Equine veterinary journal

Effect of frusemide on transvascular fluid fluxes across the lung in exercising horses.

Vengust M, Kerr C, Staempfli H R, Pringle J, Heigenhauser G J, Viel L(2011)Equine veterinary journal

Effects of an external nasal strip and frusemide on pulmonary haemorrhage in Thoroughbreds following high-intensity exercise.

Geor R J, Ommundson L, Fenton G, Pagan J D(2001)Equine veterinary journal

The effects of frusemide on racing times of Standardbred pacers.

Soma L R, Birks E K, Uboh C E, May L, Teleis D, Martini J(2000)Equine veterinary journal

Clenbuterol administration does not attenuate the exercise-induced pulmonary arterial, capillary or venous hypertension in strenuously exercising Thoroughbred horses.

Manohar M, Goetz T E, Rothenbaum P, Humphrey S(2000)Equine veterinary journal